Literature DB >> 16239235

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

G Stuart1, E Avall-Lundqvist, A du Bois, M Bookman, D Bowtell, M Brady, A Casado, A Cervantes, E Eisenhauer, M Friedlaender, K Fujiwara, S Grenman, J P Guastalla, P Harper, T Hogberg, S Kaye, H Kitchener, G Kristensen, R Mannel, W Meier, B Miller, A Oza, R Ozols, M Parmar, J Pfisterer, A Poveda, D Provencher, E Pujade-Lauraine, M Quinn, M Randall, J Rochon, G Rustin, S Sagae, F Stehman, E Trimble, T Thigpen, P Vasey, I Vergote, R Verheijen, J Vermorken, U Wagner.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16239235     DOI: 10.1093/annonc/mdi965

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol.

Authors:  Nathalie Rochet; Alexandra D Jensen; Florian Sterzing; Marc W Munter; Michael H Eichbaum; Andreas Schneeweiss; Christof Sohn; Juergen Debus; Wolfgang Harms
Journal:  BMC Cancer       Date:  2007-12-19       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.